Skip to results
Modify your search
NARROW
1-12 of 12
Authors: Brad Poore
Journal Article
Retrospective Evaluation of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score Free
The Journal of Applied Laboratory Medicine, Volume 7, Issue 1, January 2022, Pages 36–45, https://doi.org/10.1093/jalm/jfab106
Published: 05 January 2022
Journal Article
Gamma Glutamyl Transferase Activity Has Limited Utility in Assessment of Alkaline Phosphatase Elevations Free
The Journal of Applied Laboratory Medicine, Volume 6, Issue 6, November 2021, Pages 1623–1627, https://doi.org/10.1093/jalm/jfab085
Published: 20 August 2021
Journal Article
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_2, July 2021, Page ii15, https://doi.org/10.1093/noajnl/vdab070.060
Published: 05 July 2021
Journal Article
FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi.org/10.1093/noajnl/vdab024.081
Published: 25 March 2021
Journal Article
MBRS-63. THE ROLE OF THE SWI/SNF COMPLEX SUBUNIT SMARCD3 IN MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii409, https://doi.org/10.1093/neuonc/noaa222.567
Published: 04 December 2020
Journal Article
CSIG-21. BAF60C/SMARCD3 REGULATES TUMOR CELL DISSEMINATION IN MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii32, https://doi.org/10.1093/neuonc/noaa215.133
Published: 09 November 2020
Journal Article
LGG-09. PD-L1 EXPRESSION IN PEDIATRIC LOW GRADE GLIOMAS, AN OPPORTUNITY FOR INTERVENTION INDEPENDENT OF BRAF MUTATIONAL STATUS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii100, https://doi.org/10.1093/neuonc/noz036.152
Published: 23 April 2019
Journal Article
ATRT-04. UNBIASED METABOLIC PROFILING OF ATYPICAL TERATOID/RHABDOID TUMORS PREDICTS SENSITIVITY TO GLUTAMINE METABOLIC INHIBITORS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii63, https://doi.org/10.1093/neuonc/noz036.003
Published: 23 April 2019
Journal Article
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin Free
Neuro-Oncology, Volume 21, Issue 2, February 2019, Pages 252–263, https://doi.org/10.1093/neuonc/noy150
Published: 18 September 2018
Journal Article
MBRS-61. IN VIVO METABOLOMICS REVEALS A POTENT COMBINATION THERAPY FOR MYC-DRIVEN MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i141, https://doi.org/10.1093/neuonc/noy059.505
Published: 22 June 2018
Journal Article
LGG-51. METABOLIC PROFILING IN PEDIATRIC LOW GRADE GLIOMA IDENTIFIES GLUTATHIONE DEPLETION AFTER MTORC1 INHIBITION AND VALIDATES EVEROLIMUS AND CARBOPLATIN AS A POTENTIAL COMBINATION THERAPY Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i115, https://doi.org/10.1093/neuonc/noy059.392
Published: 22 June 2018
Journal Article
LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS Free
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv36, https://doi.org/10.1093/neuonc/nox083.148
Published: 31 May 2017
